| 1 |
27698808 | Increase of T and B cells and altered BACH2 expression patterns in bone marrow trephines of imatinib-treated patients with chronic myelogenous leukaemia. | 2016 Oct |
2 |
| 2 |
23040543 | Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia. | 2013 Jan |
1 |
| 3 |
21113055 | Molecular target therapy in hematological malignancy: front-runners and prototypes of small molecule and antibody therapy. | 2011 Feb |
1 |
| 4 |
21533122 | Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. | 2011 Apr 18 |
1 |
| 5 |
15293570 | Existence of leukemic clones resistant to both imatinib mesylate and rituximab before drug therapies in a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. | 2004 Jul |
2 |